Search for: "Berry v. State of California, et al" Results 1 - 20 of 21
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Oct 2022, 4:09 am by Bill Marler
All batches and dates of Pams brand Mixed Berries 500-gram, Two Berry Mix 1-kilogram and 750-gram, Smoothie Berry Mix 500-gram, and raspberries 500-gram and 350-gram are involved. [read post]
2 May 2017, 7:19 am by Docket Navigator
California Berry Cultivars, LLC, et al, 3-16-cv-02477 (CAND April 27, 2017, Order) (Chhabria, USDJ) [read post]
4 Nov 2023, 9:09 pm by Ilana Korchia
Some cases also related to travel to Italy.Severi et al., 2015[21]; EFSA 2014[22]; Chiapponi et al., 2014[23]; Rizzo et al., 2013[24]; Guzman-Herrador et al., 2014[25]; Fitzgerald et al., 2014[26]2013165Pomegranate arils (frozen)Arizona, California, Colorado, Hawaii, New Hampshire, New Jersey, New Mexico, Nevada, Utah, WisconsinTurkeyUnknownCollier et al., 2014[27]; CDC… [read post]
16 Oct 2022, 6:51 pm by Bill Marler
As of May 31, 2022, a total of 18 outbreak-associated cases of hepatitis A have been reported from 3 statesCalifornia (16), Minnesota (1), and North Dakota (1). [read post]
17 Feb 2017, 1:34 pm by Bill Marler
In total, 134 people with hepatitis A have been reported from nine states: Arkansas (1), California (1), Maryland (12), New York (3), North Carolina (1), Oregon (1), Virginia (107), West Virginia (7), and Wisconsin (1). [read post]
20 Feb 2017, 5:03 pm by Bill Marler
The products were distributed to California, Hawaii, and Nevada. [read post]
1 Jul 2019, 9:03 pm by Guest Contributor
Rangel et al. 20054 reported that 41 percent of outbreaks were linked to beef and 21 percent to leafy vegetables. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]